Cochlear implantation has long been established as a transformative surgical intervention in the management of severe to profound sensorineural hearing loss. However, recent investigations highlight a ...
Six months after becoming the first patient in the United States to receive a newly FDA-approved cochlear implant system, ...
LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...
ST. PAUL, Minn., Jan. 14, 2026 /PRNewswire/ -- iotaMotion, Inc., creator of iotaSOFT ®, the first and only FDA cleared robotic-assisted cochlear implant insertion system, today announced U.S. Food and ...
MONDAY, Oct. 6, 2025 (HealthDay News) -- Most patients with Meniere disease (MD) who undergo cochlear implantation (CI) in the MD-affected ear have stability or improvement of vestibular symptoms, ...
The new Osia® System with Osia OSI300 Implant enables patients to undergo MRI at 3.0 Tesla (T) without the need for surgery This has been made possible by the OSI300's unique Piezo Power™ technology ...
LONE TREE, Colo., Jan. 8, 2026 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, is proud to announce that the groundbreaking Nucleus® Nexa® System is now available to ...
Reviewed by Aaron Miller, MD, Professor of Neurology, Icahn School of Medicine at Mount Sinai and Medical Director at the Corinne Goldsmith Dickinson Center for Multiple Sclerosis, New York, NY Among ...